[144] Bio-Rad Laboratories, Inc. SEC Filing

Rhea-AI Filing Summary

Silgan Holdings Inc. (NYSE: SLGN) filed a Form 8-K (Item 8.01) announcing that its Board of Directors declared a quarterly cash dividend of $0.20 per share. The dividend will be paid on September 16, 2025 to shareholders of record at the close of business on September 2, 2025. A press release containing the same information is included as Exhibit 99.1. No other material events, financial results, or strategic actions were disclosed in this filing.

Positive

• Board declared a $0.20 quarterly cash dividend per share, payable September 16 2025 to shareholders of record on September 2 2025.

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine dividend declaration; signals continued shareholder returns but no new financial metrics or strategic updates.

The 8-K strictly communicates a standard quarterly dividend of $0.20 per share, matching Silgan’s prior payout level (prior levels not stated in filing). Payment and record dates—16 Sep 2025 and 2 Sep 2025—are clearly defined. Because the filing lacks earnings data, guidance, or operational commentary, the announcement is largely procedural. For income-focused investors, the dividend affirms consistency of cash distributions, but it does not materially alter the company’s investment thesis. Overall market impact should be minimal, with trading already pricing in regular dividends.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1488	410571.64	27062491	08/05/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/05/2021	Restricted Stock	Issuer			302	09/05/2021	Not Applicable
Common	09/03/2021	Restricted Stock	Issuer			280	09/03/2021	Not Applicable
Common	09/11/2020	Restricted Stock	Issuer			302	09/11/2020	Not Applicable
Common	09/04/2021	Restricted Stock	Issuer			302	09/04/2021	Not Applicable
Common	09/07/2021	Restricted Stock	Issuer			302	09/07/2021	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What dividend did Silgan Holdings (SLGN) declare on August 5 2025?

The Board declared a $0.20 per-share quarterly cash dividend.

When is the dividend payment date for SLGN shareholders?

The dividend will be paid on September 16 2025.

What is the record date for Silgan's latest dividend?

Shareholders must be on record by September 2 2025 to receive the dividend.

What SEC form did Silgan file to announce the dividend?

Silgan filed a Form 8-K under Item 8.01 (Other Events).

Does the 8-K include any financial results or guidance?

No. The filing only addresses the dividend declaration; no financial statements or guidance were provided.